Bristol-Myers Squibb Is A Great Buy - Cramer's Lightning Round (3/21/16)

|
Includes: BMY, CHTR, CYBR, FTNT, GS, PANW, RDUS, SPGI, SYMC
by: SA Editor Mohit Manghnani

Summary

Don't bet against Goldman Sachs, its trading at book value.

Radius Health is speculative, but too low to ignore.

McGraw-Hill Financial has issued a lot of debt.

Stocks discussed on the Lightning Round segment of Jim Cramer's Mad Money Program, Monday, March 21.

Bullish Calls

Time Warner Cable (TWC): Technician Tim Collins had recommended it due to the technical strength of the stock and the merger. Cramer said Tim was right and he likes the stock.

Bristol-Myers Squibb (NYSE:BMY): They are unbelievably good in Cramer's opinion. He remains bullish on the stock.

Goldman Sachs (NYSE:GS): The next quarter might no be good, but it's not a good idea to bet against Goldman trading at book value.

Radius Health (NASDAQ:RDUS): This is a highly speculative stock. It's too low for Cramer to ignore.

Neutral Call

Symantec (NASDAQ:SYMC): Although not similar, Cramer likes Palo Alto (NYSE:PANW), Fortinet (NASDAQ:FTNT) and CyberArk (NASDAQ:CYBR) over Symantec.

Bearish Call

McGraw-Hill Financial (MHFI): The company has issued a lot of debt lately. Cramer advised taking profits off the table.

::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::

Jim Cramer's Action Alerts PLUS: Check out Cramer's multi-million dollar charitable trust portfolio and uncover the stocks he thinks could be HUGE winners. Start your FREE 14-day trial now!

Get Cramer's Picks by email - It's free and takes only a few seconds to sign up.